Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
Antineoplastic Combined Chemotherapy Protocols
Hematopoietic Stem Cell Transplantation
There was a high response rate with low treatment-related mortality, with 26% of patients alive in remission 3.3 years after transplantation.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency